0
USD
EUR USD GBP
+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Biopharmaceutical TPE Tubing Market by Material Type, End User - Global Forecast to 2030

  • PDF Icon

    Report

  • 198 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 6055698
UP TO EUR$697USDGBP OFF until Dec 31st 2025
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Biopharmaceutical TPE Tubing Market is entering a pivotal phase of transformation as advances in manufacturing and increased regulatory scrutiny drive demand for innovative, high-performance tubing solutions. Senior leaders are elevating material strategy, supply chain agility, and product differentiation as core priorities to ensure future-fit operations in a rapidly changing landscape.

Market Snapshot: Biopharmaceutical TPE Tubing Market

The biopharmaceutical TPE tubing market exhibited substantial growth, rising from USD 2.45 billion in 2024 to USD 2.68 billion in 2025. Projections indicate sustained expansion at a CAGR of 9.37%, bringing the market value to USD 4.21 billion by 2030. Industry stakeholders are investing in advanced tubing technologies to meet the evolving needs of biologics production, personalized medicine, and continuous processing platforms, all underpinned by robust compliance mandates and enhanced operational reliability.

Scope & Segmentation

  • Material Types: The market is segmented by material, including styrenic block copolymers, thermoplastic polyolefin elastomers, thermoplastic polyurethanes, and thermoplastic vulcanisates. Each offers unique balances of durability, flexibility, and chemical stability tailored to specific bioprocessing needs.
  • End Users: Core end-user groups are contract development and manufacturing organizations (CDMOs), pharmaceutical companies, and research laboratories, each with distinct priorities regarding batch scalability, supply assurance, and qualification protocols.
  • Geographies: The report covers primary global regions: Americas (including major US states, Canada, Mexico, Brazil, Argentina), Europe, Middle East, and Africa (with detailed country breakdowns), and Asia-Pacific (including China, India, Japan, and Southeast Asian nations).
  • Technologies & Applications: Single-use tubing, sensor-enabled assemblies, and recyclable or bio-based elastomer innovations are focal technology themes. Digitalization facilitates process monitoring, traceability, and predictive maintenance.
  • Competitive Landscape: Company profiles feature global and regional manufacturers, OEMs, and specialist providers with strategies spanning clean-room expansion, M&A activity, and co-development initiatives.

Key Takeaways for Senior Decision-Makers

  • Single-use TPE tubing is now core to bioprocessing, supporting sterility, modularity, and rapid changeover in manufacturing environments that serve advanced therapeutics.
  • Material scientists are advancing recyclable and bio-based tubing options, directly supporting environmental objectives and greening manufacturing footprints.
  • Digitalization is enabling new capabilities in monitoring and maintenance, allowing organizations to anticipate needs and enhance operational efficiency.
  • Customer segmentation demands targeted solutions: CDMOs require scalable and rapidly qualified tubing, pharmaceutical companies seek robust global supply, and research labs value flexibility and speed to experimentation.
  • Regional diversity in regulatory environments and manufacturing maturity shapes adoption rates, risk profiles, and partnership strategies across global markets.
  • Strategic investment in advanced elastomer development and digital manufacturing techniques enables organizations to accelerate product life cycles and better serve evolving biopharma needs.

Tariff Impact on Supply Chains

The introduction of higher US tariffs in 2025 on select thermoplastic elastomer components disrupted international supply flows. Manufacturers responded by altering sourcing, renegotiating terms, and prioritizing local supplier qualification. This volatility has driven a shift toward near-shoring and regionalized production, reducing reliance on overseas supply but introducing new challenges in investment and regulatory timelines. Organizations that diversified sourcing early have buffered against operational disruptions and held cost stability more effectively than peers.

Methodology & Data Sources

This research utilizes primary inputs—executive interviews and structured industry surveys—and secondary data from filings, company reports, and published analyses. Triangulation and third-party expert validation underpin key assumptions, while segmentation and competitor benchmarking form the basis of the analytical framework.

Why This Report Matters

  • Enables informed investment and maturation strategies based on transparent segmentation and technology trends within the biopharmaceutical TPE tubing market.
  • Supports senior leaders in evaluating supply chain resilience and regulatory alignment in a dynamic and competitive environment.
  • Provides actionable insights for product development, regional expansion, and risk management based on current and future market drivers.

Conclusion

Success in the biopharmaceutical TPE tubing market relies on material innovation, agile supply networks, and segment-specific solutions. Decision-makers equipped with rigorous intelligence are poised for growth as standards advance and competition intensifies.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Biopharmaceutical TPE Tubing Market, by Material Type
8.1. Introduction
8.2. Styrenic Block Copolymers
8.3. Thermoplastic Polyolefin Elastomer
8.4. Thermoplastic Polyurethanes
8.5. Thermoplastic Vulcanisates
9. Biopharmaceutical TPE Tubing Market, by End User
9.1. Introduction
9.2. Contract Development & Manufacturing Organization
9.3. Pharmaceutical Companies
9.4. Research Labs
10. Americas Biopharmaceutical TPE Tubing Market
10.1. Introduction
10.2. United States
10.3. Canada
10.4. Mexico
10.5. Brazil
10.6. Argentina
11. Europe, Middle East & Africa Biopharmaceutical TPE Tubing Market
11.1. Introduction
11.2. United Kingdom
11.3. Germany
11.4. France
11.5. Russia
11.6. Italy
11.7. Spain
11.8. United Arab Emirates
11.9. Saudi Arabia
11.10. South Africa
11.11. Denmark
11.12. Netherlands
11.13. Qatar
11.14. Finland
11.15. Sweden
11.16. Nigeria
11.17. Egypt
11.18. Turkey
11.19. Israel
11.20. Norway
11.21. Poland
11.22. Switzerland
12. Asia-Pacific Biopharmaceutical TPE Tubing Market
12.1. Introduction
12.2. China
12.3. India
12.4. Japan
12.5. Australia
12.6. South Korea
12.7. Indonesia
12.8. Thailand
12.9. Philippines
12.10. Malaysia
12.11. Singapore
12.12. Vietnam
12.13. Taiwan
13. Competitive Landscape
13.1. Market Share Analysis, 2024
13.2. FPNV Positioning Matrix, 2024
13.3. Competitive Analysis
13.3.1. Avantor, Inc.
13.3.2. Avient Corporation
13.3.3. BiomatiQ Scientific Pvt. Ltd.
13.3.4. DowDuPont Inc.
13.3.5. Eldon James Corporation
13.3.6. Entegris, Inc.
13.3.7. FOXX Life science
13.3.8. Freudenberg Medical
13.3.9. IDEX Health & Science LLC
13.3.10. Medline Industries, LP
13.3.11. Meridian Industries, Inc
13.3.12. NewAge Industries, Inc.
13.3.13. Nordson Corporation
13.3.14. Optinova Holding Ab
13.3.15. Qosina Corp.
13.3.16. Raumedic AG
13.3.17. Saint-Gobain Performance Plastics Corporation
13.3.18. SaniSure
13.3.19. Seisa Group
13.3.20. TE Connectivity Ltd.
13.3.21. Tekni-Plex, Inc.
13.3.22. Thermo Fisher Scientific Inc.
13.3.23. W. L. Gore & Associates, Inc.
13.3.24. Watson-Marlow Fluid Technology Group
13.3.25. WHK BioSystemss, LLC.
14. ResearchAI
15. ResearchStatistics
16. ResearchContacts
17. ResearchArticles
18. Appendix
List of Figures
FIGURE 1. BIOPHARMACEUTICAL TPE TUBING MARKET MULTI-CURRENCY
FIGURE 2. BIOPHARMACEUTICAL TPE TUBING MARKET MULTI-LANGUAGE
FIGURE 3. BIOPHARMACEUTICAL TPE TUBING MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY MATERIAL TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY MATERIAL TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 10. GLOBAL BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. AMERICAS BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 12. AMERICAS BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. UNITED STATES BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 14. UNITED STATES BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. BIOPHARMACEUTICAL TPE TUBING MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 20. BIOPHARMACEUTICAL TPE TUBING MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. BIOPHARMACEUTICAL TPE TUBING MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY STYRENIC BLOCK COPOLYMERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY THERMOPLASTIC POLYOLEFIN ELASTOMER, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY THERMOPLASTIC POLYURETHANES, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY THERMOPLASTIC VULCANISATES, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY RESEARCH LABS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. AMERICAS BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 16. AMERICAS BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 17. AMERICAS BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 18. UNITED STATES BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 19. UNITED STATES BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 20. UNITED STATES BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 21. CANADA BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 22. CANADA BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 23. MEXICO BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 24. MEXICO BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 25. BRAZIL BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 26. BRAZIL BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 27. ARGENTINA BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 28. ARGENTINA BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 29. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 30. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 31. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 32. UNITED KINGDOM BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 33. UNITED KINGDOM BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 34. GERMANY BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 35. GERMANY BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 36. FRANCE BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 37. FRANCE BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 38. RUSSIA BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 39. RUSSIA BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 40. ITALY BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 41. ITALY BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 42. SPAIN BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 43. SPAIN BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 44. UNITED ARAB EMIRATES BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 45. UNITED ARAB EMIRATES BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 46. SAUDI ARABIA BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 47. SAUDI ARABIA BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 48. SOUTH AFRICA BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 49. SOUTH AFRICA BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 50. DENMARK BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 51. DENMARK BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 52. NETHERLANDS BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 53. NETHERLANDS BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 54. QATAR BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 55. QATAR BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 56. FINLAND BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 57. FINLAND BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 58. SWEDEN BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 59. SWEDEN BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 60. NIGERIA BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 61. NIGERIA BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 62. EGYPT BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 63. EGYPT BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 64. TURKEY BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 65. TURKEY BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 66. ISRAEL BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 67. ISRAEL BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 68. NORWAY BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 69. NORWAY BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 70. POLAND BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 71. POLAND BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 72. SWITZERLAND BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 73. SWITZERLAND BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 74. ASIA-PACIFIC BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 75. ASIA-PACIFIC BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 76. ASIA-PACIFIC BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 77. CHINA BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 78. CHINA BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 79. INDIA BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 80. INDIA BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 81. JAPAN BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 82. JAPAN BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 83. AUSTRALIA BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 84. AUSTRALIA BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 85. SOUTH KOREA BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 86. SOUTH KOREA BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 87. INDONESIA BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 88. INDONESIA BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 89. THAILAND BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 90. THAILAND BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 91. PHILIPPINES BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 92. PHILIPPINES BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 93. MALAYSIA BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 94. MALAYSIA BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 95. SINGAPORE BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 96. SINGAPORE BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 97. VIETNAM BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 98. VIETNAM BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 99. TAIWAN BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 100. TAIWAN BIOPHARMACEUTICAL TPE TUBING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 101. BIOPHARMACEUTICAL TPE TUBING MARKET SHARE, BY KEY PLAYER, 2024
TABLE 102. BIOPHARMACEUTICAL TPE TUBING MARKET, FPNV POSITIONING MATRIX, 2024

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Biopharmaceutical TPE Tubing market report include:
  • Avantor, Inc.
  • Avient Corporation
  • BiomatiQ Scientific Pvt. Ltd.
  • DowDuPont Inc.
  • Eldon James Corporation
  • Entegris, Inc.
  • FOXX Life science
  • Freudenberg Medical
  • IDEX Health & Science LLC
  • Medline Industries, LP
  • Meridian Industries, Inc
  • NewAge Industries, Inc.
  • Nordson Corporation
  • Optinova Holding Ab
  • Qosina Corp.
  • Raumedic AG
  • Saint-Gobain Performance Plastics Corporation
  • SaniSure
  • Seisa Group
  • TE Connectivity Ltd.
  • Tekni-Plex, Inc.
  • Thermo Fisher Scientific Inc.
  • W. L. Gore & Associates, Inc.
  • Watson-Marlow Fluid Technology Group
  • WHK BioSystemss, LLC.

Table Information

This website uses cookies to ensure you get the best experience. Learn more